Free Trial

Aerovate Therapeutics (AVTE) Insider Trading & Ownership

$2.04
-0.01 (-0.49%)
(As of 10/9/2024 ET)

Aerovate Therapeutics (NASDAQ:AVTE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$3.94 M
Get AVTE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aerovate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AVTE Insider Buying and Selling by Quarter

Aerovate Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2024George A EldridgeInsiderSell15,000$25.03$375,450.00  
5/17/2024Hunter GilliesInsiderSell4,000$21.08$84,320.00  
5/16/2024Timothy P. NoyesCEOSell10,000$21.58$215,800.00  
5/2/2024Marinus VerwijsInsiderSell1,981$21.02$41,640.62  
5/1/2024Timothy P. NoyesCEOSell11,357$20.34$231,001.38  
4/17/2024Benjamin T DakeInsiderSell6,853$22.37$153,301.61  
4/16/2024Timothy P. NoyesCEOSell10,000$24.70$247,000.00  
4/10/2024George A EldridgeInsiderSell7,500$26.85$201,375.00  
4/9/2024David S GrayzelDirectorSell11,882$28.15$334,478.30  
4/1/2024Benjamin T DakeInsiderSell3,325$31.97$106,300.25  
4/1/2024Timothy P. NoyesCEOSell10,000$30.00$300,000.00  
3/27/2024Benjamin T DakeInsiderSell11,068$27.97$309,571.96  
3/25/2024Benjamin T DakeInsiderSell3,432$28.01$96,130.32  
3/19/2024Marinus VerwijsinsiderSell5,300$26.08$138,224.00  
3/13/2024George A EldridgeInsiderSell2,016$25.02$50,440.32  
3/11/2024George A EldridgeInsiderSell3,433$25.25$86,683.25  
3/8/2024George A EldridgeInsiderSell114$25.00$2,850.00  
2/23/2024Hunter GilliesInsiderSell511$19.50$9,964.50  
2/20/2024Hunter GilliesInsiderSell3,489$20.23$70,582.47  
2/5/2024Ralph NivenInsiderSell4,600$17.45$80,270.00  
1/17/2024Hunter GilliesInsiderSell4,000$19.50$78,000.00  
1/5/2024Ralph NivenInsiderSell4,600$19.16$88,136.00  
12/27/2023Hunter GilliesInsiderSell125$24.50$3,062.50  
12/20/2023Hunter GilliesInsiderSell4,000$19.50$78,000.00  
12/13/2023Hunter GilliesInsiderSell2,103$19.50$41,008.50  
12/5/2023Ralph NivenInsiderSell4,600$16.30$74,980.00  
11/27/2023Benjamin T DakeInsiderSell12,517$16.24$203,276.08  
11/24/2023Benjamin T DakeInsiderSell4,990$15.74$78,542.60  
11/22/2023Benjamin T DakeInsiderSell9,382$15.17$142,324.94  
11/1/2023Marinus VerwijsCTOSell970$10.46$10,146.20  
11/1/2023Timothy P. NoyesCEOSell1,092$10.42$11,378.64  
(Data available from 1/1/2013 forward)

AVTE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Aerovate Therapeutics includes Benjamin T Dake, David S Grayzel, George A Eldridge, Hunter Gillies, Marinus Verwijs, Ralph Niven, Timothy P Noyes. Learn more on insiders at AVTE.

24.90% of Aerovate Therapeutics stock is owned by insiders. Learn more on AVTE's insider holdings.

The following insiders have sold AVTE shares in the last 24 months: Benjamin T Dake ($1,703,746.76), David S Grayzel ($334,478.30), George A Eldridge ($1,346,413.23), Hunter Gillies ($465,558.57), Marinus Verwijs ($227,136.13), Ralph Niven ($366,033.50), and Timothy P Noyes ($309,150.00).

Insiders have sold a total of 423,026 Aerovate Therapeutics shares in the last 24 months for a total of $9,203,533.13 sold.



This page (NASDAQ:AVTE) was last updated on 10/10/2024 by MarketBeat.com Staff
From Our Partners